How can an adult opioid‑tolerant patient on 1200 mg daily Kadian (extended‑release oral morphine) be safely converted to methadone?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 24, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Converting 1200 mg Daily Kadian to Methadone

For a patient on 1200 mg daily oral morphine (Kadian), cross-titration with methadone is strongly recommended rather than direct conversion, with an initial methadone dose not exceeding 30 mg daily divided into 3-4 doses, while gradually tapering the morphine. 1

Why Cross-Titration is Critical at This Dose

  • At morphine doses ≥800 mg daily, the NCCN guidelines explicitly state that "higher dose ratio is necessary and cross titration is recommended" rather than using standard conversion ratios 1
  • The conversion ratio becomes increasingly unpredictable at very high morphine doses—methadone becomes disproportionately more potent as baseline opioid doses increase 1, 2
  • Deaths have been reported during conversion from chronic high-dose opioid therapy to methadone, even in opioid-tolerant patients 3

Recommended Cross-Titration Protocol

Initial Methadone Dosing

  • Start methadone at 30 mg daily maximum, divided into 3-4 doses (e.g., 10 mg every 8 hours or 7.5 mg every 6 hours) 1, 2
  • This conservative starting dose is supported by research showing that a fixed maximum of 30 mg/day methadone produced meaningful pain improvement in patients on >1200 mg morphine equivalent daily without adverse effects 2
  • Do NOT calculate a theoretical equianalgesic dose at this morphine level—the standard conversion tables stop at 800 mg for safety reasons 1

Morphine Tapering Strategy

  • Continue the full 1200 mg Kadian dose initially while starting methadone 1
  • After 3-5 days (allowing methadone tissue stores to accumulate), begin reducing Kadian by 25-50% every 3-5 days while monitoring pain control 1, 3
  • Provide immediate-release morphine 10-15% of remaining daily Kadian dose for breakthrough pain during the transition 1

Titration Timeline

  • Methadone may be titrated upward every 5-7 days by 5-10 mg per dose based on pain control after morphine is fully discontinued 1
  • Methadone's long and variable half-life (24-36 hours) means steady-state is not reached for 5-7 days after each dose change 1, 3
  • Most patients stabilize between 80-120 mg/day methadone for maintenance, though this varies considerably 3

Mandatory Safety Monitoring

Cardiac Screening

  • Obtain baseline ECG before initiating methadone and repeat ECG when methadone dose exceeds 100 mg/day 1, 3
  • Methadone causes QTc prolongation and life-threatening arrhythmias, particularly at higher doses 1, 3
  • Screen for risk factors: cardiac disease, hypokalemia, hypomagnesemia, concomitant QTc-prolonging medications (including tricyclic antidepressants), diuretic use 1, 3
  • If QTc >450 ms develops, evaluate for modifiable risk factors and consider alternative opioids 3

Drug Interaction Assessment

  • Investigate potential drug-drug interactions before initiating methadone—methadone is metabolized by CYP3A4 and CYP2B6 1
  • Inhibitors (e.g., azole antifungals, macrolides, protease inhibitors) increase methadone levels and toxicity risk 1
  • Inducers (e.g., rifampin, phenytoin, carbamazepine) decrease methadone efficacy 1

Respiratory Monitoring

  • Monitor closely for respiratory depression, especially during the first 3-5 days when methadone is accumulating 3
  • Peak respiratory depressant effects occur later and persist longer than peak analgesic effects 3
  • High opioid tolerance does NOT eliminate methadone overdose risk 3

Concurrent Bowel Management

  • Prescribe stimulant laxative (senna/docusate) starting at 2 tablets every morning from day one 1, 4, 5
  • Increase laxative dose when escalating methadone—opioid-induced constipation does not improve with tolerance 1, 4, 5
  • Maintain adequate hydration 1, 4

Common Pitfalls to Avoid

  • Never use standard conversion ratios for morphine >800 mg daily—this leads to methadone overdosing 1
  • Never make same-day methadone dose increases—wait at least 5-7 days between adjustments 1, 3
  • Never abruptly discontinue the 1200 mg Kadian—cross-titration is essential at this dose level 1
  • Never assume complete cross-tolerance—incomplete cross-tolerance between opioids is particularly dangerous with methadone 3

Alternative Approach: Inpatient Titration Method

  • If inpatient specialist palliative care is available, some centers use a "10% rule": calculate 10% of morphine equivalent dose (120 mg in this case), but cap initial methadone at 40 mg daily maximum, given every 3 hours as needed 6
  • Once daily requirements stabilize (typically 2-18 days), divide into 2-3 regular doses 6
  • This method requires intensive monitoring in a specialist unit and is NOT appropriate for outpatient conversion at this dose level 6

When to Consult Pain Specialist

  • Strongly consider pain specialist consultation for any patient on >800 mg morphine daily given the complexity and mortality risk of methadone conversion 1, 7
  • Mandatory consultation if patient has cardiac conduction disease, QTc >450 ms, or complex medication regimen 1, 3

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Converting Morphine ER to Liquid Morphine

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Management of Acute Pain in Patients on Methadone

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Research

Methadone titration in opioid-resistant cancer pain.

European journal of cancer care, 1999

Research

Morphine to methadone conversion: an interpretation of published data.

The American journal of hospice & palliative care, 2011

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.